Medical Therapy for NF2-related Schwannomatosis: A Systematic Review of Current Evidence
Listen to this summary
The authors aim to synthesize the existing evidence on medical therapies for managing NF2-related vestibular schwannomas. Their systematic review reveals that bevacizumab shows the most consistent efficacy in improving hearing and controlling tumors, while other therapies like mTOR inhibitors and tyrosine kinase inhibitors exhibit variable outcomes. The authors emphasize the need for high-quality, prospective randomized controlled trials to better understand the efficacy and comparative effectiveness of these treatments.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
View all →Jun 11, 2026 · Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
Early Identification and Management of Otogenic and Nonotogenic Cerebral Venous Sinus Thrombosis
Jun 10, 2026 · Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
Efficacy of Vestibular Rehabilitation Therapy on Benign Paroxysmal Positional Vertigo After Repositioning: Improvement of Vestibular Symptoms and Vertigo Disability
More in Otolaryngology
View all →Nov 19, 2026 · Lancet (London, England)
Reproductive health in women in Britain from 2010 to 2024: findings from repeated, cross-sectional National Surveys of Sexual Attitudes and Lifestyles (Natsal).
Nov 19, 2026 · Lancet (London, England)
Seasonal mass vaccination with R21/Matrix-M against malaria in The Gambia and Burkina Faso: an open-label, cluster-randomised, controlled trial.
Nov 19, 2026 · Lancet (London, England)
Spontaneous coronary artery dissection: implications for women's health, clinical care, and future research.
Nov 19, 2026 · JAMA
Plasma eMTBR-tau as a Biomarker for Chronic Traumatic Encephalopathy Tau Tangle Neuropathology.
Nov 19, 2026 · The New England journal of medicine
Assessing Multiple Treatment Regimens for Tuberculosis.
Nov 19, 2026 · JAMA
Medical Imaging and Pediatric and Adolescent Brain Tumor Risk.
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


